Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David I Bernstein

Showing results (91-100 of 379) with videos related to

Pageof 38
Sort By:
Sexually Transmitted Diseases|October 2, 2003
Viral sexually transmitted disease vaccine acceptability among college studentsConstance W Boehner, Steven R Howe, David I Bernstein, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 18, 2006
Evaluation of antibody binding to diisocyanate protein conjugates in a general populationDavid I Bernstein, M Gerald Ott, Michael Woolhiser, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 8, 2016
Risk factors for fatal and nonfatal reactions to subcutaneous immunotherapy: National surveillance study on allergen immunotherapy (2008-2013)Tolly G Epstein, Gary M Liss, Karen Murphy-Berendts, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 25, 2011
Immediate and delayed-onset systemic reactions after subcutaneous immunotherapy injections: ACAAI/AAAAI surveillance study of subcutaneous immunotherapy: year 2Tolly G Epstein, Gary M Liss, Karen Murphy-Berendts, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 6, 2017
Evaluation of the risk of infection associated with subcutaneous allergen immunotherapy: American Academy of Allergy, Asthma, and Immunology and American College of Allergy, Asthma, and Immunology National Surveillance Study on Allergen Immunotherapy, 2014-2015Tolly G Epstein, Gary M Liss, Karen Murphy-Berendts, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 11, 2014
AAAAI/ACAAI surveillance study of subcutaneous immunotherapy, years 2008-2012: an update on fatal and nonfatal systemic allergic reactionsTolly G Epstein, Gary M Liss, Karen Murphy-Berendts, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 23, 2021
Risk factors for fatal and nonfatal reactions to immunotherapy (2008-2018): postinjection monitoring and severe asthmaTolly G Epstein, Karen Murphy-Berendts, Gary M Liss, et al.
Virology|November 5, 2023
Selection, activity, and nuclease stabilization of cross-neutralizing DNA aptamers targeting HSV-1 and HSV-2Michael D Schump, David I Bernstein, Fernando J Bravo, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 19, 2019
AAAAI/ACAAI Subcutaneous Immunotherapy Surveillance Study (2013-2017): Fatalities, Infections, Delayed Reactions, and Use of Epinephrine AutoinjectorsTolly G Epstein, Gary M Liss, Karen Murphy Berendts, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 29, 2013
AAAAI and ACAAI surveillance study of subcutaneous immunotherapy, Year 3: what practices modify the risk of systemic reactions?Tolly G Epstein, Gary M Liss, Karen Murphy-Berendts, et al.
Pageof 38

Showing results (91-100 of 379) with videos related to

Sort By:
Pageof 38
Sexually Transmitted Diseases|October 2, 2003
Viral sexually transmitted disease vaccine acceptability among college studentsConstance W Boehner, Steven R Howe, David I Bernstein, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 18, 2006
Evaluation of antibody binding to diisocyanate protein conjugates in a general populationDavid I Bernstein, M Gerald Ott, Michael Woolhiser, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 8, 2016
Risk factors for fatal and nonfatal reactions to subcutaneous immunotherapy: National surveillance study on allergen immunotherapy (2008-2013)Tolly G Epstein, Gary M Liss, Karen Murphy-Berendts, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 25, 2011
Immediate and delayed-onset systemic reactions after subcutaneous immunotherapy injections: ACAAI/AAAAI surveillance study of subcutaneous immunotherapy: year 2Tolly G Epstein, Gary M Liss, Karen Murphy-Berendts, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 6, 2017
Evaluation of the risk of infection associated with subcutaneous allergen immunotherapy: American Academy of Allergy, Asthma, and Immunology and American College of Allergy, Asthma, and Immunology National Surveillance Study on Allergen Immunotherapy, 2014-2015Tolly G Epstein, Gary M Liss, Karen Murphy-Berendts, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 11, 2014
AAAAI/ACAAI surveillance study of subcutaneous immunotherapy, years 2008-2012: an update on fatal and nonfatal systemic allergic reactionsTolly G Epstein, Gary M Liss, Karen Murphy-Berendts, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 23, 2021
Risk factors for fatal and nonfatal reactions to immunotherapy (2008-2018): postinjection monitoring and severe asthmaTolly G Epstein, Karen Murphy-Berendts, Gary M Liss, et al.
Virology|November 5, 2023
Selection, activity, and nuclease stabilization of cross-neutralizing DNA aptamers targeting HSV-1 and HSV-2Michael D Schump, David I Bernstein, Fernando J Bravo, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 19, 2019
AAAAI/ACAAI Subcutaneous Immunotherapy Surveillance Study (2013-2017): Fatalities, Infections, Delayed Reactions, and Use of Epinephrine AutoinjectorsTolly G Epstein, Gary M Liss, Karen Murphy Berendts, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 29, 2013
AAAAI and ACAAI surveillance study of subcutaneous immunotherapy, Year 3: what practices modify the risk of systemic reactions?Tolly G Epstein, Gary M Liss, Karen Murphy-Berendts, et al.
Pageof 38